A carregar...
Validation Of The HAS-BLED Tool In Atrial Fibrillation Patients Receiving Rivaroxaban
Background: Atrial fibrillation (Afib) patients are at an increased risk of stroke. Patients at moderate to high risk of stroke typically receive antithrombotics, placing them at an increased risk of bleeding. The HAS-BLED tool has been validated in Afib patients receiving warfarin for prediction of...
Na minha lista:
| Publicado no: | J Atr Fibrillation |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cardiofront, Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5129694/ https://ncbi.nlm.nih.gov/pubmed/27909541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1461 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|